Document is current
Any future updates will be listed below
-
Authors
Adler, Benjamin A.
Chamakura, Karthik https://orcid.org/0000-0002-6196-8571
Carion, Heloise
Krog, Jonathan
Deutschbauer, Adam M. https://orcid.org/0000-0003-2728-7622
Young, Ry
Mutalik, Vivek K. https://orcid.org/0000-0001-7934-0400
Arkin, Adam P. https://orcid.org/0000-0002-4999-2931
-
Funding
Funding for this research was provided by:
Microbiology Program of the Innovative Genomics Institute, Berkeley
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R35GM136396, R35GM136396, R35GM136396)
- License Information
-
More Information
Article History
Received: 18 September 2022
Accepted: 18 January 2023
First Online: 20 February 2023
Competing interests
: V.K.M. is a co-founder of Felix Biotechnology. A.M.D. is an advisor to Felix Biotechnology. A.P.A. is a co-founder of Boost Biomes and Felix Biotechnology. A.P.A. is a shareholder in and advisor to Nutcracker Therapeutics. The remaining authors declare no competing interests.
